Summit Securities Group’s Nutrien NTR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-6,800
Closed -$420K 1277
2025
Q4
$420K Buy
+6,800
New +$400K 0.05% 220
2025
Q3
Sell
-2,600
Closed -$151K 1257
2025
Q2
$151K Buy
+2,600
New +$147K 0.03% 293
2025
Q1
Sell
-1,300
Closed -$58.2K 1003
2024
Q4
$58.2K Buy
1,300
+900
+225% +$42.7K 0.01% 271
2024
Q3
$19K Sell
400
-100
-20% -$4.82K 0.01% 338
2024
Q2
$25K Buy
+500
New +$27.4K ﹤0.01% 361
2023
Q3
Sell
-800
Closed -$47K 887
2023
Q2
$47K Buy
800
+500
+167% +$31.8K 0.01% 429
2023
Q1
$22K Sell
300
-6,011
-95% -$464K ﹤0.01% 614
2022
Q4
$461K Buy
6,311
+2,411
+62% +$190K 0.02% 253
2022
Q3
$325K Hold
3,900
0.02% 325
2022
Q2
$311K Sell
3,900
-1,400
-26% -$136K 0.04% 245
2022
Q1
$551K Sell
5,300
-178,200
-97% -$14.8M 0.06% 216
2021
Q4
$13.8M Buy
183,500
+178,800
+3,804% +$12.5M 0.65% 30
2021
Q3
$305K Buy
+4,700
New +$287K 0.02% 528

Other funds holding NTR

Summit Securities Group's NTR Position: Q1 2026 in Review

Summit Securities Group sold out of Nutrien (NTR) in Q1 2026, closing a stake of 6,800 shares — an estimated $420K sold.

Summit Securities Group first reported a position in NTR in Q3 2021 and held it in 13 quarters. The position peaked at $13.8M in Q4 2021. 747 funds tracked by Wall St. Rank hold NTR as of Q1 2026.

  • Summit Securities Group reported no remaining Nutrien position as of Q1 2026 after selling out during the quarter.
  • Summit Securities Group sold 6,800 Nutrien shares in Q1 2026, an estimated $420K.
  • Summit Securities Group first reported a position in Nutrien in Q3 2021 and held it in 13 quarters.
  • Summit Securities Group's Nutrien position peaked at $13.8M in Q4 2021.
  • 747 funds tracked by Wall St. Rank held Nutrien as of Q1 2026.

Based on Summit Securities Group's 13F filing for Q1 2026, filed 30 Apr 2026.